These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20587666)

  • 1. The superparamagnetic nanoparticles carrying the E1A gene enhance the radiosensitivity of human cervical carcinoma in nude mice.
    Shen LF; Chen J; Zeng S; Zhou RR; Zhu H; Zhong MZ; Yao RJ; Shen H
    Mol Cancer Ther; 2010 Jul; 9(7):2123-30. PubMed ID: 20587666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-specific gene therapy for uterine cervical cancer using MN/CA9-directed replication-competent adenovirus.
    Lim HY; Ahn M; Chung HC; Gardner TA; Kao C; Lee SJ; Kim SJ
    Cancer Gene Ther; 2004 Aug; 11(8):532-8. PubMed ID: 15167900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of intratracheal lung cancer development by systemic delivery of E1A.
    Chang JY; Xia W; Shao R; Hung MC
    Oncogene; 1996 Oct; 13(7):1405-12. PubMed ID: 8875978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.
    Chang JY; Xia W; Shao R; Sorgi F; Hortobagyi GN; Huang L; Hung MC
    Oncogene; 1997 Feb; 14(5):561-8. PubMed ID: 9053854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy.
    Itamochi H; Kigawa J; Kanamori Y; Oishi T; Bartholomeusz C; Nahta R; Esteva FJ; Sneige N; Terakawa N; Ueno NT
    Mol Cancer Ther; 2007 Jan; 6(1):227-35. PubMed ID: 17218636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel apoptotic mechanism of genetically engineered adenovirus-mediated tumour-specific p53 overexpression through E1A-dependent p21 and MDM2 suppression.
    Yamasaki Y; Tazawa H; Hashimoto Y; Kojima T; Kuroda S; Yano S; Yoshida R; Uno F; Mizuguchi H; Ohtsuru A; Urata Y; Kagawa S; Fujiwara T
    Eur J Cancer; 2012 Sep; 48(14):2282-91. PubMed ID: 22244827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation and feasibility of superparamagnetic dextran iron oxide nanoparticles as gene carrier].
    Cao ZG; Zhou SW; Sun K; Lu XB; Luo G; Liu JH
    Ai Zheng; 2004 Oct; 23(10):1105-9. PubMed ID: 15473917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E1A inhibits the proliferation of human cervical cancer cells (HeLa cells) by apoptosis induction through activation of HER-2/Neu/Caspase-3 pathway.
    Shen L; Zeng S; Chen J; Zhong M; Yang H; Yao R; Shen H
    Med Oncol; 2008; 25(2):222-8. PubMed ID: 18488161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of E1A gene on the growth and chemosensitivity of transplantation tumor of nude mice].
    Wang XL; Qian XL; Zhao QZ; Xu ZG; Tang PZ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Dec; 38(6):409-12. PubMed ID: 15040099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antitumor efficacy of IL-24 mediated by E1A and E1B triple regulated oncolytic adenovirus.
    Xiao LL; Wu YM; Qian J; Tan Y; Xie GL; Zhang KJ; Wang YG; Jia XY; Liu XY
    Cancer Biol Ther; 2010 Aug; 10(3):242-50. PubMed ID: 20574150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway.
    Ueno NT; Bartholomeusz C; Herrmann JL; Estrov Z; Shao R; Andreeff M; Price J; Paul RW; Anklesaria P; Yu D; Hung MC
    Clin Cancer Res; 2000 Jan; 6(1):250-9. PubMed ID: 10656456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin].
    Zhang Y; Lin C; Qian HL; Lang JH; Fu M; Zhang XY; Liang X; Duan H; Xiang Y
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):25-9. PubMed ID: 17575689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER-2/neu-targeting cancer therapy via adenovirus-mediated E1A delivery in an animal model.
    Zhang Y; Yu D; Xia W; Hung MC
    Oncogene; 1995 May; 10(10):1947-54. PubMed ID: 7761095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus 5 E1a-mediated gene therapy for human ovarian cancer cells in vitro and in vivo.
    Zang RY; Shi DR; Lu HJ; Cai SM; Lu DR; Zhang YJ; Qin HL
    Int J Gynecol Cancer; 2001; 11(1):18-23. PubMed ID: 11285029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.
    Li W; Tan J; Wang P; Li N; Li C
    Mol Cell Biochem; 2015 Jan; 399(1-2):279-89. PubMed ID: 25410753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
    Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
    Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated p53 treatment enhances photodynamic antitumor response.
    Lim DS; Bae SM; Kwak SY; Park EK; Kim JK; Han SJ; Oh CH; Lee CH; Lee WY; Ahn WS
    Hum Gene Ther; 2006 Mar; 17(3):347-52. PubMed ID: 16544983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome-mediated in vivo E1A gene transfer suppressed dissemination of ovarian cancer cells that overexpress HER-2/neu.
    Yu D; Matin A; Xia W; Sorgi F; Huang L; Hung MC
    Oncogene; 1995 Oct; 11(7):1383-8. PubMed ID: 7478560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-E1A gene therapy enhances the in vivo sensitivity of Ewing's sarcoma to VP-16.
    Zhou RR; Jia SF; Zhou Z; Wang Y; Bucana CD; Kleinerman ES
    Cancer Gene Ther; 2002 May; 9(5):407-13. PubMed ID: 11961663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Down regulation of HER2/neu expression by adenovirus E1A and its anti-tumor activity].
    Lu H; Qin H; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):370-3. PubMed ID: 11778270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.